Publication | Open Access

Discovery of phthalazino[1,2-b]-quinazolinone derivatives as multi-target HDAC inhibitors for the treatment of hepatocellular carcinoma via activating the p53 signal pathway

Medicinal ChemistryMedicinePharmacological AgentAnti-cancer AgentMulti-target Hdac InhibitorsP53 Signal PathwayDrug DevelopmentPharmacologyRadiation OncologyHepatocellular CarcinomaCancer ResearchDrug Discovery